Camlin Fine Sciences Intrinsic Value
Camlin Fine Sciences (CAMLINFINE) median intrinsic value is ₹249.18 from 4 valuation models (range ₹132–₹311), vs current price ₹124.59 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit CAMLINFINE company profile.
CAMLINFINE Valuation Methods Summary — DCF, Graham Number & P/E
Camlin Fine Sciences intrinsic value across 4 models vs current price ₹124.59 — upside/downside and value range per method. Browse Camlin Fine Sciences annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹311.48 | ₹280.33 - ₹342.63 | +150.0% | Book Value/Share: ₹460.53, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹249.18 | ₹224.26 - ₹274.10 | +100.0% | Revenue/Share: ₹976.84, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹249.18 | ₹224.26 - ₹274.10 | +100.0% | EBITDA: ₹116.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹131.93 | ₹105.54 - ₹158.32 | +5.9% | CF Growth: 5.0%, Discount: 15% |
CAMLINFINE Intrinsic Value vs Market Price — All Valuation Models
Camlin Fine Sciences fair value range ₹132–₹311 vs current market price ₹124.59 across 4 valuation models. Compare with CAMLINFINE fundamental valuation to assess whether the stock is under or overvalued.
CAMLINFINE Intrinsic Value Analysis — Undervalued or Overvalued?
Camlin Fine Sciences median intrinsic value ₹249.18, current price ₹124.59 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CAMLINFINE?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Camlin Fine Sciences (CAMLINFINE) is ₹249.18 (median value). With the current market price of ₹124.59, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹131.93 to ₹311.48, indicating ₹131.93 - ₹311.48.
Is CAMLINFINE undervalued or overvalued?
Based on our multi-method analysis, Camlin Fine Sciences (CAMLINFINE) appears to be trading below calculated value by approximately 100.0%.
CAMLINFINE Financial Health — Key Ratios vs Industry Benchmarks
Camlin Fine Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.90 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.92x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAMLINFINE Cash Flow Quality — Operating & Free Cash Flow
Camlin Fine Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹27 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹139 Cr | ₹106 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹51 Cr | ₹-12 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹145 Cr | ₹21 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹117 Cr | ₹51 Cr | Positive Free Cash Flow | 7/10 |